SpiroChem
Juan Martin-Lopez is a highly skilled research chemist with extensive experience in organic synthesis and medicinal chemistry. Currently employed at Spirochem since September 2022, Juan focuses on the synthesis of pharmacologically active molecules and process chemistry. Prior to this, Juan completed a PhD in Medicinal Chemistry at the University of Barcelona, where research centered on sEH inhibitors and anti-viral compounds. Previous positions included research associate roles at Eurofins Villapharma and product development at Anastorebio, alongside earlier experiences in neuropharmacology and organic catalysis research. Juan has demonstrated a strong ability in routine analysis and a deep understanding of pharmacological characterizations throughout various roles.
Previous companies
This person is not in any offices
SpiroChem
SpiroChem is an Elite Discovery Chemistry Contract Research Organization (CRO) working with clients worldwide from biotechs, pharmaceutical, agrochemical, and life science companies of all sizes. Our company, operating in Basel, Switzerland, offers unique and innovative solutions covering the entire discovery chemistry value chain: - Proprietary Screening Libraries including high-sp3 fragments, covalent fragments and macrocycles - SpiroKit as turnkey toolboxes for the medicinal chemistry community to speed up research programs - Design & Computational Team for fragment-based drug design (FBDD), structure-based drug design (SBDD) and computational-aided drug design (CADD) - Medicinal Chemistry group including experts in enabling technologies (photochemistry, photoredox, electrochemistry, biocatalysis, …) to access target molecule faster and explore uncharted chemical space - An Early Development division involved in Route Scouting projects to make the bridge between the medicinal chemistry lab and CDMOs - Thanks to two-high potent labs, SpiroChem also supports discovery in the field of ADCs (linker-payload chemistry)